APA (7th ed.) Citation

ZW, S., SR, C., BE, B., & P, N. (2023). Development of Gallium(III) as an Antimicrobial Drug Targeting Pathophysiologic Iron Metabolism of Human Pathogens. ACS infectious diseases, 9(4), 716. https://doi.org/10.1021/acsinfecdis.3c00050

Chicago Style (17th ed.) Citation

ZW, Scott, Choi SR, Britigan BE, and Narayanasamy P. "Development of Gallium(III) as an Antimicrobial Drug Targeting Pathophysiologic Iron Metabolism of Human Pathogens." ACS Infectious Diseases 9, no. 4 (2023): 716. https://doi.org/10.1021/acsinfecdis.3c00050.

MLA (9th ed.) Citation

ZW, Scott, et al. "Development of Gallium(III) as an Antimicrobial Drug Targeting Pathophysiologic Iron Metabolism of Human Pathogens." ACS Infectious Diseases, vol. 9, no. 4, 2023, p. 716, https://doi.org/10.1021/acsinfecdis.3c00050.